LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 8 of total 8

Search options

  1. Article ; Online: Value of immunonutrition in patients undergoing pancreatic resection: a trial sequential meta-analysis.

    Ricci, Claudio / Serbassi, Francesco / Alberici, Laura / Ingaldi, Carlo / Eusebi, Leonardo H / De Raffele, Emilio / Pironi, Loris / Sasdelli, Anna S / Mosconi, Cristina / Vicennati, Valentina / Casadei, Riccardo

    HPB : the official journal of the International Hepato Pancreato Biliary Association

    2023  Volume 25, Issue 10, Page(s) 1151–1160

    Abstract: Background: The benefits of immunonutrition (IM) in patients who underwent pancreatic surgery are unclear.: Methods: A meta-analysis of randomized clinical trials (RCTs) comparing IM with standard nutrition (SN) in pancreatic surgery was carried out. ...

    Abstract Background: The benefits of immunonutrition (IM) in patients who underwent pancreatic surgery are unclear.
    Methods: A meta-analysis of randomized clinical trials (RCTs) comparing IM with standard nutrition (SN) in pancreatic surgery was carried out. A random-effects trial sequential meta-analysis was made, reporting Risk Ratio (RR), mean difference (MD), and required information size (RIS). If RIS was reached, false negative (type II error) and positive results (type I error) could be excluded. The endpoints were morbidity, mortality, infectious complication, postoperative pancreatic fistula (POPF) rates, and length of stay (LOS).
    Results: The meta-analysis includes 6 RCTs and 477 patients. Morbidity (RR 0.77; 0.26 to 2.25), mortality (RR 0.90; 0.76 to 1.07), and POPF rates were similar. The RISs were 17,316, 7,417, and 464,006, suggesting a type II error. Infectious complications were lower in the IM group, with a RR of 0.54 (0.36-0.79; 95 CI). The LOS was shorter in IM (MD -0.3 days; -0.6 to -0.1). For both, the RISs were reached, excluding type I error.
    Conclusion: The IM can reduce infectious complications and LOS The small differences in mortality, morbidity, and POPF make it impossible to exclude type II error due to large RISs.
    MeSH term(s) Humans ; Immunonutrition Diet ; Pancreas/surgery ; Pancreatectomy/adverse effects ; Postoperative Complications/etiology ; Postoperative Complications/prevention & control ; Pancreatic Fistula/surgery ; Length of Stay
    Language English
    Publishing date 2023-03-28
    Publishing country England
    Document type Meta-Analysis ; Journal Article
    ZDB-ID 2131251-5
    ISSN 1477-2574 ; 1365-182X
    ISSN (online) 1477-2574
    ISSN 1365-182X
    DOI 10.1016/j.hpb.2023.03.014
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: A real-world data analysis.

    Colosimo, Santo / Ravaioli, Federico / Petroni, Maria L / Brodosi, Lucia / Marchignoli, Francesca / Barbanti, Francesca A / Sasdelli, Anna S / Marchesini, Giulio / Pironi, Loris

    Liver international : official journal of the International Association for the Study of the Liver

    2021  Volume 41, Issue 4, Page(s) 731–742

    Abstract: Background & aims: There is intense research for drugs able to reduce disease progression in nonalcoholic fatty liver disease. We aimed to test the impact of novel antidiabetic drugs (dipeptidyl-peptidase-4 inhibitors - DPP-4Is, glucagon-like peptide-1 ... ...

    Abstract Background & aims: There is intense research for drugs able to reduce disease progression in nonalcoholic fatty liver disease. We aimed to test the impact of novel antidiabetic drugs (dipeptidyl-peptidase-4 inhibitors - DPP-4Is, glucagon-like peptide-1 receptor agonists - GLP-1RAs, sodium-glucose cotransporter-2 inhibitors - SGLT-2Is) on non-invasive biomarkers of steatosis (fatty liver index, FLI) and fibrosis (Fibrosis-4 score, FIB-4) in patients with type 2 diabetes (T2D).
    Methods: Clinical, anthropometric and biochemical parameters were retrospectively analysed in 637 consecutive T2D patients switched from metformin w/wo sulfonylureas and/or pioglitazone to DPP-4Is, GLP-1RAs and SGLT-2Is in a tertiary care setting. 165 patients maintained on original treatments served as controls. The effects on FLI and FIB-4 at 6- and 12-month follow-up were analysed by logistic regression after adjustment for baseline differences, computed by propensity scores, and additional adjustment for changes in glycosylated hemoglobin (HbA1c) and body mass index.
    Results: Body mass index, HbA1c and aminotrasferases significantly decreased following switching to GLP-1RAs and SGLT2-Is, compared with both controls and DPP-4Is, whereas only HbA1c was reduced on DPP-4Is. FLI and FIB-4 were reduced on GLP-1RA and SGLT-2I; logistic regression analysis confirmed a significant improvement of both biomarkers after adjustment for propensity score. The shift of FIB-4 values towards the category ruling out advanced fibrosis was maintained after additional adjustment for confounders. These effects were confirmed in a sensitivity analysis on effect size.
    Conclusions: Glucagon-like peptide-1 receptor agonists and SGLT-2Is improve biomarkers of steatosis and fibrosis, in keeping with beneficial effects on liver disease progression, and should be considered the treatment of choice in T2D.
    MeSH term(s) Biomarkers ; Data Analysis ; Diabetes Mellitus, Type 2/drug therapy ; Fatty Liver ; Fibrosis ; Humans ; Hypoglycemic Agents/therapeutic use ; Retrospective Studies ; Sodium-Glucose Transporter 2 Inhibitors/therapeutic use
    Chemical Substances Biomarkers ; Hypoglycemic Agents ; Sodium-Glucose Transporter 2 Inhibitors
    Language English
    Publishing date 2021-02-10
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2102783-3
    ISSN 1478-3231 ; 1478-3223
    ISSN (online) 1478-3231
    ISSN 1478-3223
    DOI 10.1111/liv.14799
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Chronic Intestinal Failure in Children: An International Multicenter Cross-Sectional Survey.

    Lezo, Antonella / Diamanti, Antonella / Marinier, Evelyne M / Tabbers, Merit / Guz-Mark, Anat / Gandullia, Paolo / Spagnuolo, Maria I / Protheroe, Sue / Peretti, Noel / Merras-Salmio, Laura / Hulst, Jessie M / Kolaček, Sanja / Ee, Looi C / Lawrence, Joanna / Hind, Jonathan / D'Antiga, Lorenzo / Verlato, Giovanna / Pukite, Ieva / Di Leo, Grazia /
    Vanuytsel, Tim / Doitchinova-Simeonova, Maryana K / Ellegard, Lars / Masconale, Luisa / Maíz-Jiménez, María / Cooper, Sheldon C / Brillanti, Giorgia / Nardi, Elena / Sasdelli, Anna S / Lal, Simon / Pironi, Loris

    Nutrients

    2022  Volume 14, Issue 9

    Abstract: Background: The European Society for Clinical Nutrition and Metabolism database for chronic intestinal failure (CIF) was analyzed to investigate factors associated with nutritional status and the intravenous supplementation (IVS) dependency in children. ... ...

    Abstract Background: The European Society for Clinical Nutrition and Metabolism database for chronic intestinal failure (CIF) was analyzed to investigate factors associated with nutritional status and the intravenous supplementation (IVS) dependency in children. Methods: Data collected: demographics, CIF mechanism, home parenteral nutrition program, z-scores of weight-for-age (WFA), length or height-for-age (LFA/HFA), and body mass index-for-age (BMI-FA). IVS dependency was calculated as the ratio of daily total IVS energy over estimated resting energy expenditure (%IVSE/REE). Results: Five hundred and fifty-eight patients were included, 57.2% of whom were male. CIF mechanisms at age 1−4 and 14−18 years, respectively: SBS 63.3%, 37.9%; dysmotility or mucosal disease: 36.7%, 62.1%. One-third had WFA and/or LFA/HFA z-scores < −2. One-third had %IVSE/REE > 125%. Multivariate analysis showed that mechanism of CIF was associated with WFA and/or LFA/HFA z-scores (negatively with mucosal disease) and %IVSE/REE (higher for dysmotility and lower in SBS with colon in continuity), while z-scores were negatively associated with %IVSE/REE. Conclusions: The main mechanism of CIF at young age was short bowel syndrome (SBS), whereas most patients facing adulthood had intestinal dysmotility or mucosal disease. One-third were underweight or stunted and had high IVS dependency. Considering that IVS dependency was associated with both CIF mechanisms and nutritional status, IVS dependency is suggested as a potential marker for CIF severity in children.
    MeSH term(s) Adult ; Child ; Chronic Disease ; Cross-Sectional Studies ; Female ; Humans ; Intestinal Diseases/epidemiology ; Intestinal Diseases/therapy ; Intestinal Failure ; Male ; Parenteral Nutrition, Home ; Short Bowel Syndrome/therapy
    Language English
    Publishing date 2022-04-30
    Publishing country Switzerland
    Document type Journal Article ; Multicenter Study
    ZDB-ID 2518386-2
    ISSN 2072-6643 ; 2072-6643
    ISSN (online) 2072-6643
    ISSN 2072-6643
    DOI 10.3390/nu14091889
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Intestinal failure in adults: Recommendations from the ESPEN expert groups.

    Pironi, Loris / Corcos, Olivier / Forbes, Alastair / Holst, Mette / Joly, Francisca / Jonkers, Cora / Klek, Stanislaw / Lal, Simon / Blaser, Annika Reintam / Rollins, Katie E / Sasdelli, Anna S / Shaffer, Jon / Van Gossum, Andre / Wanten, Geert / Zanfi, Chiara / Lobo, Dileep N

    Clinical nutrition (Edinburgh, Scotland)

    2018  Volume 37, Issue 6 Pt A, Page(s) 1798–1809

    Abstract: Background & aims: Intestinal failure (IF) is defined as "the reduction of gut function below the minimum necessary for the absorption of macronutrients and/or water and electrolytes, such that intravenous supplementation is required to maintain health ... ...

    Abstract Background & aims: Intestinal failure (IF) is defined as "the reduction of gut function below the minimum necessary for the absorption of macronutrients and/or water and electrolytes, such that intravenous supplementation is required to maintain health and/or growth". Functionally, it may be classified as type I acute intestinal failure (AIF), type II prolonged AIF and type III chronic intestinal failure (CIF) The ESPEN Workshop on IF was held in Bologna, Italy, on 15-16 October 2017 and the aims of this document were to highlight the current state of the art and future directions for research in IF.
    Methods: This paper represents the opinion of experts in the field, based on current evidence. It is not a formal review, but encompasses the current evidence, with emphasis on epidemiology, classification, diagnosis and management.
    Results: IF is the rarest form of organ failure and can result from a variety of conditions that affect gastrointestinal anatomy and function adversely. Assessment, diagnosis, and short and long-term management involves a multidisciplinary team with diverse expertise in the field that aims to reduce complications, increase life expectancy and improve quality of life in patients.
    Conclusions: Both AIF and CIF are relatively rare conditions and most of the published work presents evidence from small, single-centre studies. Much remains to be investigated to improve the diagnosis and management of IF and future studies should rely on multidisciplinary, multicentre and multinational collaborations that gather data from large cohorts of patients. Emphasis should also be placed on partnership with patients, carers and government agencies in order to improve the quality of research that focuses on patient-centred outcomes that will help to improve both outcomes and quality of life in patients with this devastating condition.
    MeSH term(s) Acute Disease ; Adult ; Chronic Disease ; Europe ; Gastrointestinal Tract/physiopathology ; Humans ; Hydroxyzine ; Interdisciplinary Communication ; Intestinal Absorption ; Intestinal Diseases/diagnosis ; Intestinal Diseases/physiopathology ; Intestinal Diseases/therapy ; Intestines/physiopathology ; Nutrition Therapy/methods ; Patient-Centered Care ; Quality of Life ; Risk Factors ; Water-Electrolyte Balance
    Chemical Substances Hydroxyzine (30S50YM8OG)
    Language English
    Publishing date 2018-08-18
    Publishing country England
    Document type Journal Article ; Practice Guideline ; Research Support, Non-U.S. Gov't
    ZDB-ID 604812-2
    ISSN 1532-1983 ; 0261-5614
    ISSN (online) 1532-1983
    ISSN 0261-5614
    DOI 10.1016/j.clnu.2018.07.036
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: COVID-19 infection in patients on long-term home parenteral nutrition for chronic intestinal failure.

    Pironi, Loris / Jezerski, Denise / Sobocki, Jacek / Lal, Simon / Vanuytsel, Tim / Theilla, Miriam / Sasdelli, Anna S / Chambrier, Cecile / Matysiak, Konrad / Aimasso, Umberto / Rasmussen, Henrik H / Jukes, Amelia / Kunecki, Marek / Seguy, David / Schneider, Stéphane M / Daniels, Joanne / Poullenot, Florian / Mundi, Manpreet S / Matras, Przemysław /
    Folwarski, Marcin / Crivelli, Adriana / Wyer, Nicola / Ellegard, Lars / Santarpia, Lidia / Arvanitakis, Marianna / Spaggiari, Corrado / Lamprecht, Georg / Guglielmi, Francesco W / Lezo, Antonella / Layec, Sabrina / Boluda, Esther Ramos / Guz-Mark, Anat / Gandullia, Paolo / Cuerda, Cristina / Osland, Emma / Spagnuolo, Maria I / Krznaric, Zeljko / Masconale, Luisa / Chapman, Brooke / Maíz-Jiménez, María / Orlandoni, Paolo / Martins da Rocha, Mariana Hollanda / Virgili-Casas, M Nuria / Doitchinova-Simeonova, Maryana / Czako, Laszlo / Van Gossum, Andrè / D'Antiga, Lorenzo / Ee, Looi C / Warodomwichit, Daruneewan / Taus, Marina / Kolaček, Sanja / Thibault, Ronan / Verlato, Giovanna / Serralde-Zúñiga, Aurora E / Botella-Carretero, José I / Aguayo, Pilar Serrano / Olveira, Gabriel / Chomtho, Sirinuch / Pisprasert, Veeradej / Moisejevs, Georgijs / Murillo, Ana Zugasti / Jáuregui, Ma Estrella Petrina / Díez, Marta Bueno / Jahit, Mohammad Shukri / Densupsoontorn, Narumon / Tamer, Ali / Brillanti, Giorgia / Joly, Francisca

    Clinical nutrition ESPEN

    2023  Volume 55, Page(s) 212–220

    Abstract: Background and aims: To investigate the incidence and the severity of COVID-19 infection in patients enrolled in the database for home parenteral nutrition (HPN) for chronic intestinal failure (CIF) of the European Society for Clinical Nutrition and ... ...

    Abstract Background and aims: To investigate the incidence and the severity of COVID-19 infection in patients enrolled in the database for home parenteral nutrition (HPN) for chronic intestinal failure (CIF) of the European Society for Clinical Nutrition and Metabolism (ESPEN).
    Methods: Period of observation: March 1st, 2020 March 1st, 2021.
    Inclusion criteria: patients included in the database since 2015 and still receiving HPN on March 1st, 2020 as well as new patients included in the database during the period of observation. Data related to the previous 12 months and recorded on March 1st 2021: 1) occurrence of COVID-19 infection since the beginning of the pandemic (yes, no, unknown); 2) infection severity (asymptomatic; mild, no-hospitalization; moderate, hospitalization no-ICU; severe, hospitalization in ICU); 3) vaccinated against COVID-19 (yes, no, unknown); 4) patient outcome on March 1st 2021: still on HPN, weaned off HPN, deceased, lost to follow up.
    Results: Sixty-eight centres from 23 countries included 4680 patients. Data on COVID-19 were available for 55.1% of patients. The cumulative incidence of infection was 9.6% in the total group and ranged from 0% to 21.9% in the cohorts of individual countries. Infection severity was reported as: asymptomatic 26.7%, mild 32.0%, moderate 36.0%, severe 5.3%. Vaccination status was unknown in 62.0% of patients, non-vaccinated 25.2%, vaccinated 12.8%. Patient outcome was reported as: still on HPN 78.6%, weaned off HPN 10.6%, deceased 9.7%, lost to follow up 1.1%. A higher incidence of infection (p = 0.04), greater severity of infection (p < 0.001) and a lower vaccination percentage (p = 0.01) were observed in deceased patients. In COVID-19 infected patients, deaths due to infection accounted for 42.8% of total deaths.
    Conclusions: In patients on HPN for CIF, the incidence of COVID-19 infection differed greatly among countries. Although the majority of cases were reported to be asymptomatic or have mild symptoms only, COVID-19 was reported to be fatal in a significant proportion of infected patients. Lack of vaccination was associated with a higher risk of death.
    MeSH term(s) Humans ; COVID-19/epidemiology ; Intestinal Failure ; Intestinal Diseases/epidemiology ; Intestinal Diseases/therapy ; Parenteral Nutrition, Home/adverse effects
    Language English
    Publishing date 2023-03-30
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 2405-4577
    ISSN (online) 2405-4577
    DOI 10.1016/j.clnesp.2023.03.008
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: COVID-19 infection in patients on long-term home parenteral nutrition for chronic intestinal failure

    Pironi, Loris / Jezerski, Denise / Sobocki, Jacek / Lal, Simon / Vanuytsel, Tim / Theilla, Miriam / Sasdelli, Anna S. / Chambrier, Cecile / Matysiak, Konrad / Aimasso, Umberto / Rasmussen, Henrik H. / Jukes, Amelia / Kunecki, Marek / Seguy, David / Schneider, Stéphane M. / Daniels, Joanne / Poullenot, Florian / Mundi, Manpreet S. / Matras, Przemysław /
    Folwarski, Marcin / Crivelli, Adriana / Wyer, Nicola / Ellegard, Lars / Santarpia, Lidia / Arvanitakis, Marianna / Spaggiari, Corrado / Lamprecht, Georg / Guglielmi, Francesco W. / Lezo, Antonella / Layec, Sabrina / Boluda, Esther Ramos / Guz-Mark, Anat / Gandullia, Paolo / Cuerda, Cristina / Osland, Emma / Spagnuolo, Maria I. / Krznaric, Zeljko / Masconale, Luisa / Chapman, Brooke / Maíz-Jiménez, María / Orlandoni, Paolo / Martins da Rocha, Mariana Hollanda / Virgili-Casas, M. Nuria / Doitchinova-Simeonova, Maryana / Czako, Laszlo / Gossum, Andre van / D'Antiga, Lorenzo / Ee, Looi C. / Warodomwichit, Daruneewan / Taus, Marina / Kolaček, Sanja / Thibault, Ronan / Verlato, Giovanna / Serralde-Zúñiga, Aurora E. / Botella-Carretero, José I. / Aguayo, Pilar Serrano / Olveira, Gabriel / Chomtho, Sirinuch / Pisprasert, Veeradej / Moisejevs, Georgijs / Murillo, Ana Zugasti / Jáuregui, Ma Estrella Petrina / Díez, Marta Bueno / Jahit, Mohammad Shukri / Densupsoontorn, Narumon / Tamer, Ali / Brillanti, Giorgia / Joly, Francisca

    European Society for Clinical Nutrition and Metabolism Clinical Nutrition ESPEN. 2023 June, v. 55 p.212-220

    2023  

    Abstract: To investigate the incidence and the severity of COVID-19 infection in patients enrolled in the database for home parenteral nutrition (HPN) for chronic intestinal failure (CIF) of the European Society for Clinical Nutrition and Metabolism (ESPEN). ... ...

    Abstract To investigate the incidence and the severity of COVID-19 infection in patients enrolled in the database for home parenteral nutrition (HPN) for chronic intestinal failure (CIF) of the European Society for Clinical Nutrition and Metabolism (ESPEN). Period of observation: March 1st, 2020 March 1st, 2021. Inclusion criteria: patients included in the database since 2015 and still receiving HPN on March 1st, 2020 as well as new patients included in the database during the period of observation. Data related to the previous 12 months and recorded on March 1st 2021: 1) occurrence of COVID-19 infection since the beginning of the pandemic (yes, no, unknown); 2) infection severity (asymptomatic; mild, no-hospitalization; moderate, hospitalization no-ICU; severe, hospitalization in ICU); 3) vaccinated against COVID-19 (yes, no, unknown); 4) patient outcome on March 1st 2021: still on HPN, weaned off HPN, deceased, lost to follow up. Sixty-eight centres from 23 countries included 4680 patients. Data on COVID-19 were available for 55.1% of patients. The cumulative incidence of infection was 9.6% in the total group and ranged from 0% to 21.9% in the cohorts of individual countries. Infection severity was reported as: asymptomatic 26.7%, mild 32.0%, moderate 36.0%, severe 5.3%. Vaccination status was unknown in 62.0% of patients, non-vaccinated 25.2%, vaccinated 12.8%. Patient outcome was reported as: still on HPN 78.6%, weaned off HPN 10.6%, deceased 9.7%, lost to follow up 1.1%. A higher incidence of infection (p = 0.04), greater severity of infection (p < 0.001) and a lower vaccination percentage (p = 0.01) were observed in deceased patients. In COVID-19 infected patients, deaths due to infection accounted for 42.8% of total deaths. In patients on HPN for CIF, the incidence of COVID-19 infection differed greatly among countries. Although the majority of cases were reported to be asymptomatic or have mild symptoms only, COVID-19 was reported to be fatal in a significant proportion of infected patients. Lack of vaccination was associated with a higher risk of death.
    Keywords COVID-19 infection ; clinical nutrition ; databases ; death ; intestines ; metabolism ; pandemic ; parenteral feeding ; patients ; risk ; vaccination ; COVID-19 ; SARS-CoV-2 ; Home parenteral nutrition ; Intestinal failure ; Epidemiology
    Language English
    Dates of publication 2023-06
    Size p. 212-220.
    Publishing place Elsevier Ltd
    Document type Article ; Online
    ISSN 2405-4577
    DOI 10.1016/j.clnesp.2023.03.008
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  7. Article ; Online: Characteristics of adult patients with chronic intestinal failure due to short bowel syndrome: An international multicenter survey.

    Pironi, Loris / Steiger, Ezra / Joly, Francisca / Jeppesen, Palle B / Wanten, Geert / Sasdelli, Anna S / Chambrier, Cecile / Aimasso, Umberto / Mundi, Manpreet S / Szczepanek, Kinga / Jukes, Amelia / Theilla, Miriam / Kunecki, Marek / Daniels, Joanne / Serlie, Mireille / Poullenot, Florian / Cooper, Sheldon C / Rasmussen, Henrik H / Compher, Charlene /
    Seguy, David / Crivelli, Adriana / Santarpia, Lidia / Guglielmi, Francesco W / Kozjek, Nada Rotovnik / Schneider, Stéphane M / Ellegard, Lars / Thibault, Ronan / Matras, Przemysław / Matysiak, Konrad / Van Gossum, Andrè / Forbes, Alastair / Wyer, Nicola / Taus, Marina / Virgili, Nuria M / O'Callaghan, Margie / Chapman, Brooke / Osland, Emma / Cuerda, Cristina / Udvarhelyi, Gábor / Jones, Lynn / Won Lee, Andre D / Masconale, Luisa / Orlandoni, Paolo / Spaggiari, Corrado / Díez, Marta Bueno / Doitchinova-Simeonova, Maryana / Serralde-Zúñiga, Aurora E / Olveira, Gabriel / Krznaric, Zeljko / Czako, Laszlo / Kekstas, Gintautas / Sanz-Paris, Alejandro / Jáuregui, Mª Estrella Petrina / Murillo, Ana Zugasti / Schafer, Eszter / Arends, Jann / Suárez-Llanos, José P / Youssef, Nader N / Brillanti, Giorgia / Nardi, Elena / Lal, Simon

    Clinical nutrition ESPEN

    2021  Volume 45, Page(s) 433–441

    Abstract: Background and aims: The case-mix of patients with intestinal failure due to short bowel syndrome (SBS-IF) can differ among centres and may also be affected by the timeframe of data collection. Therefore, the ESPEN international multicenter cross- ... ...

    Abstract Background and aims: The case-mix of patients with intestinal failure due to short bowel syndrome (SBS-IF) can differ among centres and may also be affected by the timeframe of data collection. Therefore, the ESPEN international multicenter cross-sectional survey was analyzed to compare the characteristics of SBS-IF cohorts collected within the same timeframe in different countries.
    Methods: The study included 1880 adult SBS-IF patients collected in 2015 by 65 centres from 22 countries. The demographic, nutritional, SBS type (end jejunostomy, SBS-J; jejuno-colic anastomosis, SBS-JC; jejunoileal anastomosis with an intact colon and ileocecal valve, SBS-JIC), underlying disease and intravenous supplementation (IVS) characteristics were analyzed. IVS was classified as fluid and electrolyte alone (FE) or parenteral nutrition admixture (PN). The mean daily IVS volume, calculated on a weekly basis, was categorized as <1, 1-2, 2-3 and >3 L/day.
    Results: In the entire group: 60.7% were females and SBS-J comprised 60% of cases, while mesenteric ischaemia (MI) and Crohn' disease (CD) were the main underlying diseases. IVS dependency was longer than 3 years in around 50% of cases; IVS was infused ≥5 days/week in 75% and FE in 10% of cases. Within the SBS-IF cohort: CD was twice and thrice more frequent in SBS-J than SBS-JC and SBS-JIC, respectively, while MI was more frequent in SBS-JC and SBS-JIC. Within countries: SBS-J represented 75% or more of patients in UK and Denmark and 50-60% in the other countries, except Poland where SBS-JC prevailed. CD was the main underlying disease in UK, USA, Denmark and The Netherlands, while MI prevailed in France, Italy and Poland.
    Conclusions: SBS-IF type is primarily determined by the underlying disease, with significant variation between countries. These novel data will be useful for planning and managing both clinical activity and research studies on SBS.
    MeSH term(s) Adult ; Cross-Sectional Studies ; Female ; Humans ; Intestinal Diseases/epidemiology ; Intestinal Diseases/therapy ; Intestines ; Parenteral Nutrition ; Short Bowel Syndrome/epidemiology ; Short Bowel Syndrome/therapy
    Language English
    Publishing date 2021-07-28
    Publishing country England
    Document type Journal Article ; Multicenter Study ; Research Support, Non-U.S. Gov't
    ISSN 2405-4577
    ISSN (online) 2405-4577
    DOI 10.1016/j.clnesp.2021.07.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Characteristics of adult patients with chronic intestinal failure due to short bowel syndrome: An international multicenter survey

    Pironi, Loris / Steiger, Ezra / Joly, Francisca / Jeppesen, Palle B. / Wanten, Geert / Sasdelli, Anna S. / Chambrier, Cecile / Aimasso, Umberto / Mundi, Manpreet S. / Szczepanek, Kinga / Jukes, Amelia / Theilla, Miriam / Kunecki, Marek / Daniels, Joanne / Serlie, Mireille / Poullenot, Florian / Cooper, Sheldon C. / Rasmussen, Henrik H. / Compher, Charlene /
    Seguy, David / Crivelli, Adriana / Santarpia, Lidia / Guglielmi, Francesco W. / Kozjek, Nada Rotovnik / Schneider, Stéphane M. / Ellegard, Lars / Thibault, Ronan / Matras, Przemysław / Matysiak, Konrad / Van Gossum, Andrè / Forbes, Alastair / Wyer, Nicola / Taus, Marina / Virgili, Nuria M. / O'Callaghan, Margie / Chapman, Brooke / Osland, Emma / Cuerda, Cristina / Udvarhelyi, Gábor / Jones, Lynn / Won Lee, Andre D. / Masconale, Luisa / Orlandoni, Paolo / Spaggiari, Corrado / Díez, Marta Bueno / Doitchinova-Simeonova, Maryana / Serralde-Zúñiga, Aurora E. / Olveira, Gabriel / Krznaric, Zeljko / Czako, Laszlo / Kekstas, Gintautas / Sanz-Paris, Alejandro / Jáuregui, Mª Estrella Petrina / Murillo, Ana Zugasti / Schafer, Eszter / Arends, Jann / Suárez-Llanos, José P. / Youssef, Nader N. / Brillanti, Giorgia / Nardi, Elena / Lal, Simon / Crivelli, Adriana N. / Muñiz, Hector Solar / Chapman, Brooke R. / Hodgson, Ruth / Wallin, Siobhan / Lasenby, Kay / Van Gossum, Andre / Won Lee, Andre Dong / Rasmussen, Henrik Højgaard / Brandt, Chrisoffer / Boehm, Vanessa / Bataille, Julie / Billiauws, Lore / Molnar, Tomas / Zsilak-Urban, Mihaly / Izbéki, Ferenc / Sahin, Peter / Sasdelli, Anna Simona / Dario, Merlo F. / Bertasi, Valentino / Regano, Nunzia / Lidia, Santarpia / Alfonsi, Lucia / Busni, Debora / Gillanders, Lyn / Zmarzly, Anna / Bueno, Marta / Garde, Carmen / Jáuregui, Ma Estrella Petrina / Jonker, Cora / Di Caro, Simona / Keane, Niamh / Patel, Pinal / Nelson Hughes, Sarah-Jane / Lloyd, Rachel / Abraham, Arun / Garside, Gerda / Taylor, Michael / Wu, Jian / Smith, Trevor / Pither, Charlotte / Stroud, Michael / Parmar, Reena / Burch, Nicola / Zeraschi, Sarah / Mundi, Manpreet / Jezerski, Denise

    European Society for Clinical Nutrition and Metabolism Clinical nutrition ESPEN. 2021 Oct., v. 45

    2021  

    Abstract: The case-mix of patients with intestinal failure due to short bowel syndrome (SBS-IF) can differ among centres and may also be affected by the timeframe of data collection. Therefore, the ESPEN international multicenter cross-sectional survey was ... ...

    Institution The Home Artificial Nutrition and Chronic Intestinal Failure Special Interest Group of ESPEN
    The European Society for Clinical Nutrition and Metabolism
    Abstract The case-mix of patients with intestinal failure due to short bowel syndrome (SBS-IF) can differ among centres and may also be affected by the timeframe of data collection. Therefore, the ESPEN international multicenter cross-sectional survey was analyzed to compare the characteristics of SBS-IF cohorts collected within the same timeframe in different countries.The study included 1880 adult SBS-IF patients collected in 2015 by 65 centres from 22 countries. The demographic, nutritional, SBS type (end jejunostomy, SBS-J; jejuno-colic anastomosis, SBS-JC; jejunoileal anastomosis with an intact colon and ileocecal valve, SBS-JIC), underlying disease and intravenous supplementation (IVS) characteristics were analyzed. IVS was classified as fluid and electrolyte alone (FE) or parenteral nutrition admixture (PN). The mean daily IVS volume, calculated on a weekly basis, was categorized as <1, 1–2, 2–3 and >3 L/day.In the entire group: 60.7% were females and SBS-J comprised 60% of cases, while mesenteric ischaemia (MI) and Crohn’ disease (CD) were the main underlying diseases. IVS dependency was longer than 3 years in around 50% of cases; IVS was infused ≥5 days/week in 75% and FE in 10% of cases. Within the SBS-IF cohort: CD was twice and thrice more frequent in SBS-J than SBS-JC and SBS-JIC, respectively, while MI was more frequent in SBS-JC and SBS-JIC. Within countries: SBS-J represented 75% or more of patients in UK and Denmark and 50-60% in the other countries, except Poland where SBS-JC prevailed. CD was the main underlying disease in UK, USA, Denmark and The Netherlands, while MI prevailed in France, Italy and Poland.SBS-IF type is primarily determined by the underlying disease, with significant variation between countries. These novel data will be useful for planning and managing both clinical activity and research studies on SBS.
    Keywords adults ; clinical nutrition ; colon ; cross-sectional studies ; data collection ; electrolytes ; intravenous injection ; ischemia ; parenteral feeding ; surveys ; Denmark ; France ; Italy ; Netherlands ; Poland
    Language English
    Dates of publication 2021-10
    Size p. 433-441.
    Publishing place Elsevier Ltd
    Document type Article
    ISSN 2405-4577
    DOI 10.1016/j.clnesp.2021.07.004
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

To top